JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 10.30
-0.30 (-2.83%)
At close: Jan 21, 2026
JFL Life Sciences Revenue
JFL Life Sciences had revenue of 414.92M INR in the half year ending September 30, 2025, with 100.44% growth. This brings the company's revenue in the last twelve months to 744.78M, down -1.19% year-over-year. In the fiscal year ending March 31, 2025, JFL Life Sciences had annual revenue of 820.42M with 74.49% growth.
Revenue (ttm)
744.78M
Revenue Growth
-1.19%
P/S Ratio
0.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
339.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 820.42M | 350.23M | 74.49% |
| Mar 31, 2024 | 470.19M | 28.09M | 6.35% |
| Mar 31, 2023 | 442.10M | 99.00M | 28.85% |
| Mar 31, 2022 | 343.10M | 15.40M | 4.70% |
| Mar 31, 2021 | 327.70M | 25.99M | 8.61% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| ANG Lifesciences India | 922.09M |
| Deccan Health Care | 847.12M |
| Walpar Nutritions | 757.46M |
| Sandu Pharmaceuticals | 667.62M |
| Gujarat Terce Laboratories | 501.95M |
| Panjon | 463.51M |